digital currency industry Knowledge graph

Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Musk showed that robots conquer rugged terrain without relying on visual system. Tesla released a video showing the latest progress of its humanoid robot Optimus walking on complex terrain. The video shows that Optimus can walk steadily on a hill slope covered with mulch. Tesla CEO Elon Musk said on social media that the robot can control its electric limbs through neural networks and can walk on this rugged terrain without remote control.The fund sentiment continues to pick up, and the rebound of A shares is expected to continue! Half-day turnover of Shanghai and Shenzhen 300ETF South (159925) exceeded 90 million yuan. By midday on December 10th, Shanghai and Shenzhen 300ETF South (159925) had increased by 1.83%, with a turnover of 90299400 yuan. Component stocks rose strongly, with China Ping An, China Merchants Bank and Wuliangye rising by over 3%, while Kweichow Moutai, Midea Group and Contemporary Amperex Technology Co., Limited rising by over 2%. In the news, the Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting on December 9th to analyze and study the economic work in 2025. The meeting stressed that it is necessary to "implement more active and promising macro policies." Galaxy Securities said that looking forward to the market outlook, from the macro event point of view, the US interest rate cut is expected to heat up in December, and the superimposed domestic PMI data performed well. The follow-up policy stimulus and financial data are expected to support the continuous recovery of capital sentiment, which can be appropriately optimistic. In addition, there have been many discussions on the upcoming meeting recently, and there are still strong expectations for stimulus policies. Next, the policy landing will be an important factor affecting whether the market style can be changed. If the fundamentals are expected to improve, the large and medium-sized stocks are expected to change their trend. We can pay attention to the opportunities of medium-term investment, that is, look for the turning point of the industry boom in 2025, such as new energy, medicine, advanced manufacturing, Hong Kong stock Internet and so on.

At the close of early trading, the main contracts of domestic futures rose more and fell less. Coke and BR rubber rose by more than 3%, while rebar, glass, hot coil, iron ore and Shanghai Bank rose by more than 2%. In terms of decline, the European line of container transportation fell by nearly 3%, while asphalt, alumina and No.20 glue fell by more than 1%.Saudi Arabia said that Israel's attack on Syria violated international law.The contracted sales of Xuhui Holding Group in November was 2.27 billion yuan, a year-on-year decrease of 41%.

With the return of high dividend assets, the market pays attention to the investment value of dividend sector. The Standard & Poor's dividend ETF(562060) rose by 1.07% at midday. By midday on December 10th, the standard & poor's dividend ETF(562060) rose by 1.07%, with a turnover of 20,646,600 yuan. The constituent stocks rose strongly, with Yongxing Materials rising by 3.73%, Aopu Technology rising by 2.12%, Lu 'an Huaneng rising by 2%, Gaoce shares and Jianfa shares rising one after another. In the news, recently, the strong performance of China bond market led to the decline of the yield of 10-year treasury bonds, which fell below the key point of 2.0%, and the dividend assets in the A-share market ushered in an upward trend. Insiders pointed out that the decline in the cost performance of bond allocation is a long-term dimensional reason for supporting the dominance of the dividend sector. With the continuous decline of the yield of 10-year treasury bonds, institutional investors' confirmation of the long-term low interest rate environment will be conducive to the continuous excavation of the value of dividend assets.The scientific and technological innovation sector is ready to go! Kechuang 100TF (588190) rose by 2.99% at midday, and Stevie rose by 6.20%. By midday on December 10th, Kechuang 100TF (588190) rose by 2.99%, with a turnover of 457 million yuan. Component stocks rose strongly, with Sitway rising by 6.20%, Guo Dun Quantum, Hengxuan Technology, Ruichuang Micro-Nano and Alice rising by over 3%, and Xinyuanwei and Anji Technology rising by over 2%. Guotai Junan said that the policy is set to be unconventional, the New Year's market is expected to continue, and the China stock market's transformation bull is taking shape, and its style and industry configuration are welcoming the "transformation bull" and its chess eyes are growing. Zhongtai Securities said that the meeting pointed out that "a more active fiscal policy and a moderately loose monetary policy should be implemented". The statement that monetary policy is "moderately loose" is the first time in many years, which indicates that a more powerful monetary policy tool will be used next year, but it does not mean relaxing the goal of stabilizing exchange rate and currency value. The easing of monetary policy throughout the year is still closely related to Trump's tax cuts, inflation and debt. Next year is the closing year of the "14th Five-Year Plan", which is the real main line of the technology and direction related to industrial policy or the "year-end and early year" market.US prosecutors have filed murder charges against the suspect in the murder of a joint health executive.